Collectively, these observations underscore the essential role of intact insulin signaling in channeling glucose into metabolic and antioxidative pathways that support HNSCC progression and suggest that targeting this axis may offer a novel therapeutic strategy to counteract the protumorigenic effects of PI3K signaling. Here, PIK3CA is linked to head and neck squamous cell carcinoma.